Sequoia Capital Invests Rs 70Cr In Biopharma Firm Celon
BY Madhav A Chanchani
Sequoia, which has already invested in GVK Biosciences and Sai Advantium, continues to bet on lifescience space.
Sequoia Capital India has invested Rs 70 crore ($16 million) in Hyderabad-based biopharmaceutical company Celon Labs, which has established brands in oncology, critical care and gynaecology segments.
The funds will be used by the firm to expand its...
To continue reading this article, you must be a Premium subscriber...
A Premium membership gives you:
- Access to all premium articles including exclusives, analyses & commentary.
- Access to archives of over six years.
- Exclusive interviews with top fund managers, CEOs and bankers.